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Abstract
Human genome research depends upon participants who donate genetic samples, but few studies
have explored in depth the motivations of genetic research donors. This mixed methods study
examines telephone interviews with 752 sample donors in a U.S. genetic epidemiology study
investigating colorectal cancer. Quantitative and qualitative results indicate that most participants
wanted to help society, and that many also wanted information about their own health, even
though such information was not promised. Qualitative analysis reveals that donors believed their
samples contributed to a scientific “common good”; imagined samples as information rather than
tissues; and often blurred distinctions between research and diagnostic testing of samples.
Differences between African American and White perspectives were distinct from educational and
other possible explanatory factors.
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Understanding the motivations and perceptions of donors and potential donors of genetic
samples is crucial to genomic research, especially since previous research has shown that
some populations are less willing than others to give samples and/or to authorize their
storage for future use (McQuillan et al., 2003; Wang et al., 2001). Quantitative studies have
examined both public support for genetic research and differences in levels of support
among groups with differing demographic characteristics and differing beliefs about
genetics and research. However, few studies have explored these attitudes qualitatively to
better understand why some people choose to participate in genetic research and how they
understand that participation. To address these issues, we adopted a mixed methods
approach to understanding the motivations and perceptions of people who donated
biological samples for genetic research. Using structured interviews with 752 participants
who previously gave samples for a study of possible genetic factors in colorectal cancer, we
present a theoretically grounded exploration of why donors choose to give samples for
genetic research, and how they believe their samples will be used.
Background
Some aspects of genetic research participation, such as informed consent and the use of
stored samples, have received considerable attention (see Chen et al., 2005; Ducournau,
2007; Ludman et al., 2010; Skolbekken et al., 2005). A small number of studies have
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empirically examined the motivations of actual or potential genetic sample donors and their
notions of how samples might be used, presenting quantitative data about group differences
in motivations and views. These data reveal both general support for genetic research and
differences in support associated with demographic and other group characteristics.
Wang et al. (2001), for example, used data from the 1998 American Healthstyles Survey and
found that 79 percent of respondents favored blood donation for genetic research, long-term
storage of samples for genetic research, or both. Those who favored both donation and
storage (42 percent) also tended to believe that genetic research would prevent disease, to
hold genetic deterministic views, and to be willing to participate in government research.
This group was more likely to be White, to be more highly educated, to live in the mid-
Atlantic or Mountain/Pacific regions, and to have a family history of a genetic disorder.
Similarly, Mezuk, Eaton, and Zandi (2008), in a Baltimore-area survey in the U.S., found
that 83 percent of participants were willing to donate biological samples for genetic
research. Younger participants were more likely to donate than older ones, as were those
with a family history of related genetic conditions. African Americans were as likely as
Whites to donate, but less likely to agree to DNA storage for future research. A community-
based study in Sweden (Hoeyer et al., 2004) found that while 71 percent of respondents
would approve of genetic research on their biobanked samples, 62 percent disapproved of
researchers examining their medical records without specific consent. About a third saw
informed consent as an important issue, but most saw larger-scale justice issues as more
important, especially insuring that all population groups have equal access to research
results, and that research be readily applicable.
Fewer studies have conducted in-depth explorations of attitudes and motivations of genetic
sample donors that would provide a more nuanced understanding of differences identified in
quantitative reports. Treloar et al.’s (2007) pilot study interviewed 16 endometriosis study
participants and found that most described their motivations in altruistic terms, and few
noted any concerns for consent or privacy. Participants also expressed a desire for more
information from the researchers about the condition under study. Another particularly
interesting qualitative study is Reddy’s (2007) ethnographic examination of International
HapMap Project sample collection from the Houston-area Indian American community.
Reddy documented conflicting narratives among sample donors and researchers, though
each group employed similar language about the “good,” the “public,” and the
“community.” Divergent articulations of scientific progress, the gift, and the common good
reflected fundamentally different understandings of the purpose and use of donated samples.
Following on this finding, Reddy argued that HapMap scientists could never fully honor the
donors’ desires that their blood be used by scientists in the spirit of public service in which it
was given. While these findings have profound implications for understanding the meaning
of genetic research for a particular population, it is less clear how they can be translated into
practical recommendations for recruiting genetic research participants who are asked to
donate biological specimens. This study attempts to bridge these gaps between quantitative
and qualitative study results, using a theoretically grounded, mixed methods approach.
Theoretical Frameworks for the Study
Our analysis draws on sociological theories of exchange and on related anthropological
studies of the gift relationship. We also look to recent theorization on new formations of
selfhood in an era of increased genetic information.
Exchange Theory: Sources of Trust and Social Solidarity
Exchange theory, which has benefited from years of experimental research, offers a useful
framework for analyzing the motivations and beliefs of tissue sample donors (see Molm,
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2000 for a summary). With an emphasis on mutual benefits, sociologists distinguish
between direct and generalized exchange. The process of donating biological samples
includes features of both types. Superficially, donation is a direct exchange in which
participants give samples to a research project in return for monetary compensation, and for
other direct emotional rewards that may far outweigh the small sum of money donors
receive. However, there is a clear sense in which donors are also participating in a
generalized exchange, one in which the potential beneficiaries of research using those
biological samples may include innumerable people, perhaps many years into the future.
Research has demonstrated that while generalized exchanges offer fewer certainties of
benefits, they promote trust and social solidarity more than direct exchanges (Kollock, 1994;
Molm, Collett, & Schaefer, 2007). Based on these studies, in our analysis we expected
mixed indicators of trust and strong indicators of social solidarity to emerge in tissue sample
donors’ discussion of their donation.
Gift Theory: Relationships and Obligations
Anthropologies of non-state societies generated complex theories of the gift and its social
and economic implications (Malinowski, 1922; Mauss, 1954 [1925]). While these theories
gave rise to exchange theory within sociology and its insights into trust and social rewards,
theories of the gift are valuable here mainly for their understanding of the character of the
gift in complex social systems and, in particular, how the inalienability of gifts forms
relationships between giver and receiver. A basic tenet of gift theory is that a gift always
entails a relationship, because gifts, unlike commodities, are never completely alienated
from the giver. They always entail giving part of oneself; thus the receiver is compelled to
reciprocate and complete the social bond. Richard Titmuss (1971) extended this logic to
argue against the selling and buying of human blood. Titmuss’s contention, that blood
donation promoted social cohesion by creating a cycle of interdependence among citizens,
while commoditization of blood promoted social fragmentation by severing the relationship
between seller and receiver, greatly influenced the development of blood banking in the
U.K. and the U.S. Indeed, blood (and, more recently, other bodily substances such as DNA
samples) could be the ultimate form of inalienable gift, or “keeping-while-giving” (Weiner,
1992). Unlike blood donation for transfusion, however, in DNA sample donation it is not the
substance (of saliva or blood) that is the crucial gift: instead, it is the gift of information that
is precious and inalienable—both completely unique to an individual and an identifier of
kinship and ancestry. Bodily substances decay and are renewed; while losing too much of
them causes weakness or even death, giving of them in small amounts is simple, even
inconsequential. The information that resides in these substances, however, is never fully
separable from the individual, family, and larger kin group from whom it is obtained. An
expectation that this gift entails a relationship with, and obligations on the part of,
researchers is likely inherent in the act of gifting such an intimate component of self (Fisher,
2008). With these principles in mind, in our analysis we expected genetic research
participants to talk about their sample donation often in terms of its information content,
rather than in terms of its physical substance. We also expected that many participants
would feel that the researchers were obligated to them in some sense, a point we expand
upon below.
Genetic Responsibility: Self-Knowledge and Mitigating Risk
The emergence of genetic technologies has led to new possibilities for diagnosis and
treatment, but also to new dilemmas, including the creation of the person “genetically at
risk.” These new forms of self-knowledge have given rise to a “somatic individual,”
constrained in novel ways by the possibilities and limitations encoded in his or her genome,
and expected to take responsibility for these. This newly generated “genetic responsibility”
obliges an individual to calculate future risks and re-evaluate relationships with actual or
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potential genetic kin (Novas & Rose, 2000). These emergent forms of selfhood, within a
political climate emphasizing personal responsibility for one’s future, have also been
described as a “neoliberal medical subjectivity,” one that seeks to maximize future health
through risk aversion and informed decision making (Waldby & Mitchell, 2006). Given
these trends, in our analysis we expected that many who agreed to donate biological samples
for genetic research would look for medical benefits to themselves. Such overestimation of
benefit from research participation is often called a “therapeutic misconception”
(Appelbaum, Roth, & Lidz, 1982) and has given rise to appeals for more thorough processes
of informed consent. But more recent studies have shown that research participants are
active co-creators of their understandings of these documents (Dixon-Woods et al., 2007),
and of their multiple, overlapping roles in the research setting (Morris & Balmer, 2006),
suggesting that varying interpretations of participation in the research endeavor are, to some
degree, inevitable. In addition to diverse interpretations, given the particular historical
context of race relations in the U.S., we expected that African Americans might look for
individualized benefits more frequently, due to well-documented distrust that they will
benefit equally from medical advancements (Corbie-Smith, 1999; Corbie-Smith, Thomas, &
St. George, 2002; Schulz, Caldwell, & Foster, 2003).
Methods
Learning About Research in North Carolina (LeARN) and North Carolina Colorectal Cancer
Study (NCCCS) Sample
Learning About Research in North Carolina (LeARN) is a cross-sectional study of African
Americans and Whites who had recently participated in a case-control genetic epidemiology
study of colon cancer risk factors, the North Carolina Colorectal Cancer Study (NCCCS)
(see Corbie-Smith et al., 2008, for full description). In NCCCS, cases had an initial
diagnosis of invasive rectosigmoid cancer. Age, race, and sex matched controls were
selected from the Division of Motor Vehicles (DMV) records for individuals under the age
of 65, and from the Center for Medicare and Medicaid Services (CMS) tapes for those 65
years and older. Race/ethnicity was initially obtained from cancer registry records and DMV
or CMS files and further confirmed by self-identification during the interview. NCCCS
participants completed a two-hour in-person interview that collected data on demographics,
dietary, lifestyle and environmental exposure, and health care access and utilization. Blood
and/or a mouthwash sample were obtained from consenting participants at the conclusion of
the interview. DNA and serum were stored for future analyses. After the interview, all
NCCCS participants were asked if they were interested in hearing about other research
studies (“From time to time other research studies become available. Should such a study
become available, may we contact you?” yes/no).
Participants for the LeARN telephone interviews were identified through the NCCCS
database of participants interested in hearing about other studies. An average of four months
after the NCCCS interview, NCCCS investigators mailed potential participants a letter that
introduced the LeARN study, described the telephone interview, and alerted them to expect
a follow-up telephone call, in which an interviewer explained the nature and purpose of the
LeARN study and sought verbal consent. An incentive of $25 was mailed after completion
of the interview. A professional survey group, FGI, Inc., conducted the 45-minute telephone
surveys, consisting of both closed- and open-ended questions, using Computer Assisted
Telephone Interviewing (CATI) methods. All interviews were audio-taped and transcribed
for content analysis. Of the 1257 NCCCS participants who indicated they were willing to be
re-contacted, 1196 agreed to hear further about the LeARN study, and 810 gave verbal
consent at the start of the phone interview and participated (a response rate of 73%). Due to
technical problems such as tape errors, we analyzed slightly fewer interviews qualitatively
(N = 752), compared to those analyzed quantitatively (N = 772). All procedures were
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approved by the University of North Carolina and Emory University Institutional Review
Boards.
Measures
This paper is based on the section of the LeARN survey about donation of blood and/or
saliva, asked only of the 772 participants who provided a sample for NCCCS. This section
was preceded by questions about participants’ understanding of the purpose of the NCCCS
study; their beliefs about the causes of colorectal cancer and the sources of those beliefs; and
their understanding of genetic research and its advantages and drawbacks for them, their
families, and society. Following the section on sample donation, interviewers asked closed-
ended questions eliciting participants’ opinions about participating in genetic research and
their trust in researchers, followed by a series of demographic questions. Interviewers began
the section on sample donation by asking whether the interviewee had given blood, saliva,
or both to the NCCCS study. The small number who had refused to donate one or both were
asked their reasons (see Bussey-Jones et al., 2010, for analysis of these results). To those
who agreed to donate one or both samples, interviewers stated, “People who provide a blood
or mouthwash sample for research may do so for a variety of reasons,” and then asked,
“Could you tell me the reasons why you were willing to give mouthwash and/or blood for
the colorectal study?” Next, participants were told, “Now I’m going to read some reasons
people might be willing to give blood or mouthwash. Please tell me if each of these was a
reason for you in that study. Please answer yes or no for each.” These reasons were offered
in random order: (1) “You were interested in finding out something about your own health”;
(2) “You were interested in being a part of research on diseases that might affect your family
in the future”; (3) “You were interested in being a part of research on diseases that might
affect people of the same race as you”; and (4) “You were interested in helping people in
general.” They were then asked, “How do you think the blood and/or mouthwash that you
provided for the colorectal study will be used?”
Analysis
Our analysis combines data from interviewees’ responses to both the open-ended and
closed-ended questions described above. We used frequencies to describe demographic
information (e.g., race, age, education) and case/control status for participants who
contributed blood and/or mouthwash. Next, we explored participant characteristics for those
who chose each of our four suggested reasons for giving the blood and/or mouthwash. To
further explore our hypotheses about those who look for individual benefits from research
participation, we used Pearson’s chi-square tests to examine individual characteristics of
those who chose “own health” as a reason for participation. To assess which characteristics
were independently associated with choosing “own health” vs. any other responses as the
outcome, we fit a logistic regression model using race, education (in four categories), age (in
four categories), and case status (colorectal cancer case vs. control) as independent
variables. We also used a likelihood ratio test to determine whether there was any significant
interaction between race and education, i.e., to assess whether the race by “own health”
relationship differed by level of education. Final results from the logistic regression were
estimated as adjusted proportions (presented as adjusted percents) using the beta estimates
from the model and solving the logistic regression equation for each variable, adjusted for
the other variables in the model.
In the second stage of our analysis, we analyzed the texts of participants’ responses to
further explore and understand their reasons for donation and their understanding of sample
use. In our analysis we included both responses to open-ended questions and any extra
comments (beyond basic affirmatives or negatives) made in response to the closed-ended
question. Based on the study’s guiding questions and a preliminary reading of transcripts,
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we agreed on an initial list of descriptive content codes for all open-ended questions in the
survey, including the subset of questions asked only of donors, described above (Miles &
Huberman, 1994). Using ATLAS.ti qualitative analysis software, two independent coders
applied these content codes to all interviews, and reconciled all discrepancies by consensus.
The first author then developed interpretive content codes for the subset of questions
analyzed in this paper, based on a full reading of interview content and earlier descriptive
coding (Miles & Huberman, 1994). The first author applied and refined these interpretive
codes in successive readings of the interview texts. A second coder confirmed accuracy and
consistency of these additional codes for a ten-percent sample of interviews.
Results
Quantitative Results
Of the 801 LeARN study participants, 772 provided biological samples. Eighteen percent of
those who donated were African American, and 82% were White (Table 1). The majority
had at least a high school education and 28% had a college degree. The mean age was 64.3
years and 45% were colorectal cancer cases. There were no significant differences between
those who donated samples and those who did not for any of these participant
characteristics.
Reflecting our expectation that participants would express strong indicators of social
solidarity, almost everyone in our sample (99.7%) expressed interest in donating a blood or
mouthwash sample to help people in general, and almost as many (93.1%) wanted to be
involved in research on diseases that might affect their family in the future. A smaller, but
still fairly large percent wanted to be part of research that affected their own race (75.3%) or
wanted to find out something about their own health (70.8%). We found no differences in
responses for the first two questions (to help people in general and affect their family in the
future) by participant characteristics. For the question about research that affected their own
race, those with less education were slightly more likely to answer positively, but there were
no other differences by race, age, or case status. However, race, education, and case status
were all significantly associated with selecting own health as a reason to contribute to
research (Table 2). African Americans were more likely than Whites to choose “own health”
(88% vs. 67%). Those with the least education chose “own health” 83% of the time vs. only
56% for those with a college degree or higher. People with colorectal cancer also chose
“own health” more frequently than controls. No age differences were observed. The
estimated adjusted percents from the logistic regression model showed similar results to the
unadjusted percents (Table 2). The associations between choosing “own health” with race,
education level, and case status remained statistically significant. The differences in adjusted
percents narrowed only slightly compared to the unadjusted bivariate results, even after
controlling for the other variables in the logistic regression model. This was particularly of
note for the race and education effects; the estimated effect for race was not confounded by
education, and the estimated effect for education was not confounded by race. There also
was no significant interaction between race and education.
Qualitative Results
Several themes emerged in our qualitative analysis of LeARN sample donors’ motivations
and understandings (see Table 3 for the frequencies with which these themes appeared). We
present them in three topical groupings that correspond to the theoretical frameworks (the
exchange, the gift, and genetic responsibility) described above.
Helping Out “Down the Line”: Altruism, Trust, and Social Solidarity—“I just
thought, if it would help, I’d be willing to do it.” This statement, by a LeARN study
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participant in her seventies, sums up the most common reason that donors offered for their
willingness to give tissue samples to NCCCS. Similar to the quantitative results, most
donors, regardless of age, race, or other factors, said they were motivated by a desire to help
their families, to help other people, to help the study, and often just “to help” in general.
Participants who said that they were motivated by a desire “to help” spoke most often about
helping the study, or helpfulness in a nonspecific sense. Emily, a 61-year-old woman who
said she felt very positive about participating in a genetic research study, stated that she was
willing to donate samples because “I was hoping in some small way I could help with the
research.” Also commonplace in interviews were statements indicating that donors wanted
to help people who have or might get cancer or other health problems, and minimizing any
negative aspects of tissue donation, especially in comparison to the perceived benefit of
helping others. Frank, a White male colorectal cancer survivor, saw genetic research as an
opportunity to prevent or eliminate “inherited diseases” such as diabetes or poor eyesight.
When asked why he agreed to give samples, Frank mused, “I didn’t see any good excuse not
to, because what would it accomplish if I said, no, I’m not going to participate? I mean, that
don’t help nobody.”
Most donors spoke of the benefits of their donation as generalized to all people rather than
directly accruing to themselves (but see the later discussion of donors who also looked for
direct benefits). The future-oriented language of Arthur’s interview reflected his
understanding of research benefits as long rather than short term. A White male in the
NCCCS control group, Arthur agreed when presented with a suggestion that research
participants could be misled by researchers; nonetheless, when asked why he gave samples,
Arthur asserted, “If they can learn anything to help somebody in the future, I was for it.” In a
phrase echoed by other respondents, Joyce (a 57-year-old African American cancer
survivor) hoped that her contribution would help someone else “down the line.” Some
participants took this sense of social benefit even further, speaking about their participation
in terms of their duty as a citizen, a Christian, or simply as a human being. “If something so
simple could aid in research, if it improves one disease or one person having disease, or if it
contributed to a cure or a vaccine or something, why wouldn’t you do this?” said one donor.
“It would be a terrible world to live in if people didn’t take part in, and do whatever little bit
they can to help somebody at large.”
Perhaps related to this sense of duty to contribute to a common social good, over a quarter of
sample donors (203 of 752) made extraneous comments when asked to respond “yes” or
“no” to the question, “Were you interested in being part of research on diseases that might
affect people of the same race as you?” Many were bewildered by the question or even
offended, and many took pains to state that they did not limit the desired recipients of
benefits of research to just one race, but wanted to help all people. Similarly, donors rarely
mentioned racial or ethnic groupings in their responses to the open-ended questions (see
Table 1). Somewhat fewer interviewees (151 of 752) commented on a similar closed-ended
question that asked, “Were you interested in finding out something about your health?”
However, these comments were more mixed; many people noted that they did not expect to
find out about their own health, but participants frequently expressed a desire to receive such
information if it were available (see below).
Like many other participants, for Tom (a 48-year-old White male) tissue donation was
motivated by a desire to see causes, cures, treatments, or preventions found for cancer. A
colorectal cancer survivor, Tom “nearly died” from two surgeries and chemotherapy, and
said of his donation, “I want them to figure what really does cause it, to help come up with a
cause or prevention and new drugs.” A theme of scientific research as a long-term
undertaking again emerged from discussions of curing and treating cancer. George, a 75-
year-old who laughed that he gave samples to be “a guinea pig,” nonetheless spoke of
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studies like NCCCS as important contributors to medical advancement: “That’s the way
medicine is progressed these days, by these various types of tests and surveys and whatnot.
Each year it gets better and better.” But although Tom, George, and other participants
focused on the hope that their tissue donation would help scientists find causes or cures for
cancer, Linda and other interviewees were less specific. Fifty-one and cancer-free, Linda
simply stated, “I just felt like I could help others. I felt like it was for a good cause.”
This sense of social solidarity had its limits, however. While it was rare to hear concerns in
interviews about giving tissue samples to the study, Bill (a White, 54-year-old cancer
survivor) hinted at some ambivalence about his trust in the NCCCS researchers when he
noted, “All I can do is take them at their word for it. We only had a handshake.” Ruth, a 72-
year-old White female, had recently had surgery for her colorectal cancer at the time she
gave samples. When asked how she thought her samples would be used, she wondered, “I
don’t know whether I should have or not, but at that time I was still kind of not with it, you
know. But hopefully they [are] using it right.” The mention of topics related to trust,
consent, and confidentiality did not always indicate distrust; donors with more formal
education tended to bring up these topics more often (see Table 3), perhaps due to a greater
awareness of their significance in scientific research. For the group in our study, however,
who all elected to donate tissue samples to NCCCS, the potential benefits clearly
outweighed their concerns. This feeling was aptly expressed by Walter, a 66-year-old cancer
survivor, who recalled with some bitterness and irony that he had been in the first class of
African Americans allowed (by court order) to attend the very same university that had
gladly accepted his tissue samples. Despite his distrust of historically White institutions,
Walter did give those samples, saying, “I was very apprehensive but I just put my trust out
there, and said, I’ll just give it a shot. It’s just a gamble to make to see if it helps.”
While participants across all demographic categories overwhelmingly endorsed the value of
helping, some notable differences emerged between “cases” and “controls,” and between
older and younger donors. (African American and White donors also had somewhat
differing perspectives, discussed below.) Participants with a history of colorectal cancer
(cases) were over twice as likely as those without such a history (controls) to say they
believed or hoped their donation would help in the search for causes, treatments, or a cure
for cancer. James, a White, 64-year-old cancer survivor, noted that the diagnosis “changes
your attitude towards these things very quickly. If you had asked me these same questions a
year and a half ago, I might have had different responses.” Controls, on the other hand, were
more likely than cases to say that experience with a loved one’s cancer motivated them to
give samples. Controls were also more likely to raise issues of confidentiality, consent, and
trust in the study researchers (whether positively or negatively), though, as noted, these
topics were infrequently mentioned overall.
“To Advance the Scientists ’ Knowledge”: DNA and the Gift of Information—
The second most commonly cited motive for giving biological samples to the study, and the
way most participants thought samples would be used, was the advancement of science and
knowledge production, sometimes noting that information from samples was crucial for
research. At 75 years of age, Donald had not noted any difference in lifestyle among his
friends who had and had not developed colorectal cancer. So, he argued that collecting
samples “helps in their study. They would have to have all the information. Just talking to
somebody doesn’t give you the DNA and whatever else you might need.” Participants’
education level was directly associated with the likelihood of mentioning this sample use;
those with at least a college education were nearly twice as likely to talk about scientific
study as those who did not finish high school. Donors usually made few suppositions about
what this study might look like, saying that their samples would be used “in some type of
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research,” “to advance the scientists’ knowledge,” or, as another donor phrased it, “for the
study, whatever they’re hunting for.”
Those participants who took the further step of imagining what the research might entail
often focused on the information content of the samples. Helen, a White 75-year-old who
felt “very positive” about genetic research, said that samples “provided them information
which they would need, you know, to provide the information to us.” Also prominent was
the idea of comparisons in research, perhaps between people who have had colorectal cancer
and those who have not. “I imagine they will analyze it and compare it statistically to all the
other samples they get, and look for groupings,” offered Paul, a 71-year-old White
participant with a graduate degree. Karen, a 47-year-old White participant, mentioned
genetic information that might be obtained from the samples: “Maybe they’re looking at
some genetic markers that my blood might have that somebody else’s doesn’t have.” Pat, a
53-year-old White woman who has never had colorectal cancer, said of her sample, “Well it
has my DNA in it, so they’ll get the DNA and look at the genes.” Larry, 56-year-old White
interviewee with a bachelor’s degree, mentioned the possibility of comparative study
between samples and the lengthy lifestyle interviews conducted by NCCCS researchers,
noting that they would probably “look at the makeup of both of those samples and relate it
back to the answers I gave to the question as far as diet, health issues, and lifestyle.”
“If there’s something wrong with me, they can catch it”: Individual Thinking
and Desires for Diagnoses—Even if they did not expect to receive individual results
from the study, participants sometimes spoke about the uses of their samples more in terms
of diagnosis than of comparative study. Perhaps scientists would use samples to find out
whether the donor had cancer. Perhaps, offered David (a White 65-year-old cancer
survivor), they would “see if they find anything unusual about it.” Virginia, also surviving
colorectal cancer at 68 years old, guessed that “they’ll go in there and find germs, and
maybe where it comes from or why it’s in my system.”
For a few participants, this individualistic understanding of sample use led to an expectation
that the results of those individual assessments would be returned to them, especially if there
was “something wrong,” as Chuck (a 55-year-old White participant) put it. Mike, age 46,
had already undergone treatment for colorectal cancer; but said that he gave samples to the
study “because if they found [cancer], sure to God they would have told me.” While some
interviewees specifically noted that they knew they would never receive individual results
from the study, a few others believed that they were promised just that. Henry, a 73-year-old
White participant without cancer, recalled that “they told me they would run it like it was an
individual and said they would notify me if there was anything wrong. So I never got
notified so I figured there wasn’t nothing wrong.”
Sample donors without a history of cancer gave more varied responses in regard to this topic
than cancer survivors. On the one hand, controls were more likely to discuss how samples
would be used in terms of their individual health; to say that they gave samples, at least in
part, to find out something about their own health; and to say that they wanted individual
results from the study. But they were also slightly more likely than cases to specifically note
that they did not expect individual results.
African American study participants were more likely than their White counterparts to talk
about their sample donation in ways that emphasized individual health assessment over
comparative study. Mirroring results in the quantitative analysis, African American donors
were more likely to say they were interested in finding out something about their own health
from the study or, less frequently, that they expected or hoped for individual results to be
returned to them. White participants were more likely to mention that they had no
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expectation of receiving any information about their own health from the study; and they
were somewhat more likely to refer to some notion of scientific research or generalized
knowledge in discussing their sample donation and its use. Again, as we found in the
quantitative results after controlling for race, participants with less education were more
likely to talk about sample donation in terms of individual health, and less likely to
specifically mention that they did not expect individual results from the study.
Discussion
We found that the quantitative and qualitative results from our sample met our expectations,
which were:
• Strong indicators of social solidarity and mixed indicators of trust in discussions of
sample donation;
• Frequent discussion of samples in terms of their information content, rather than
their physical substance;
• A sense from many participants that researchers are obligated to them in some
sense; and
• A desire on the part of many participants for medical benefits to themselves,
particularly among African Americans.
The overwhelming majority of tissue sample donors honed in on the idea of “helping,”
suggesting that few donors conceived of their contribution as part of a negotiated, direct
exchange of monetary compensation for their blood, saliva, energy, and time. Rather, most
conceived of giving samples as an act of public altruism. By characterizing their donation as
an act “for the good of human-kind,” participants expressed both motivation and
expectation; researchers were recast not as direct exchange partners, but in a powerful sense
as middlemen, facilitating an exchange between citizens (of a community, of a nation, of the
world) and that of a larger society, however envisaged. It may be that researchers can play
this facilitating role in the imagination of these tissue donors precisely because of the
institutional context of a respected university research program; as Dixon-Woods and
Tarrant (2009) have proposed, beliefs that such institutions are well regulated—bolstered by
cues such as institutional credentials and consent forms as evidence of regulatory structures
—underlie decisions to cooperate with research. It is tempting to view statements
downplaying monetary compensation and foregrounding altruistic motives as, at best, self-
congratulatory, and, at worst, self-deceiving. But a justified claim of altruism can and should
be considered a major benefit that donors receive for their participation; pride in having
given something to society is itself a motivator that, for most, likely outweighs that small
sum of money. As one donor put it, “It makes me feel good about it that I have some part in
it, you know?” This feel-good “benefit” from donating tissue samples is one among many
potential benefits calculated by donors. Moreover, frequent disclaimers that their
contribution was “simple,” “a small part,” or “no trouble,” and difficulty with questions that
proposed more limited benefits (for “my individual health” or “people of my race”), suggest
that most participants measured their donation against a much larger scale—as part of a
cumulative social benefit that occurs when small individual contributions to the common
good add up. A belief in helping others out “down the line” points to a notion of these
contributions as continually returning to the individual via social advancements that
eventually benefit everyone. However flawed and incomplete these common benefits may
be in practice, a belief in the necessity of that continuing cycle of generalized exchange
clearly plays a large role in motivating people to take on the inconvenience of needles,
swabs, and lengthy interviews, and to downplay any risks of sample donation.
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This expansive view of societal benefit was not unmixed with other motives, as we describe
below; and it may also be experientially altered for some participants. Cancer survivors, who
may be more likely, as Susan Sontag (1978) put it, to identify as citizens of “the kingdom of
the sick,” focused more explicitly on benefits to their metaphorical countrymen: others who
have or may one day get cancer. They were also less likely to be among the few participants
who commented on consent, confidentiality, or trust in those traditional allies of the
“kingdom of the sick,” doctors and medical researchers. Due to their history of medical
treatment and perhaps involvement in clinical studies of their condition or patient advocacy
organizations, cancer survivors are also more closely involved in networks of medical
knowledge production than the general public. This factor may elevate their hopes and
expectations for new biomedical technologies for cancer treatment (see Brown & Michael,
2003; Novas, 2006).
In any case, participants rarely expressed any concern for the substance of the samples
themselves. Many were baffled by the idea that a mouth swab could be useful (one
participant in her forties exclaimed, “It just blows my mind—and I watch ER!”); and very
few mentioned storage of samples for future use, although an entire section of the consent
process was devoted to this possibility. It was the information content of the samples that
most donors understood as their real gift. When a tissue donor says that he gave to the study
because “I want researchers to have information they need to find a cure for this problem,”
he is expressing an equivalence in which his tissues are information. Nearly all donors
seemed to conceive of the information they contributed as residing in a biomedical
“information commons” available for the good of all (Waldby & Mitchell, 2006, pp. 135ff).
Some, like the participant who gave samples “to help research and do my part,” referred to
science as a collective endeavor that presumably works for the common good. Virtually no
participants considered any commercial or entrepreneurial uses of their sample/information.
Instead, they viewed their donation as a contribution to “help out” society as a whole. As
Reddy has said of Indian American donors to the HapMap project, the vague term
“research” is equivalent, for many, to that abstract “common good” for all of humanity that
is part of the imaginary of sample donation for genetic study (2007).
Unlike tissue donation for transfusion or transplantation, however, this donation of bodily
information is indefinitely replicable; and it is forever tied to the identity of the donor, even
more powerfully than the tissues themselves. Blood or organs that are put into another
person’s body no longer fully belong to the donor, but DNA is always “my DNA,” never
reducible to another person or to humankind in general. This truly inalienable gift demands
reciprocation, whether through, in the broadest sense, the benefits of medical advancement
extended to all people, or, in a narrower sense, acknowledgment of the giver and perhaps a
return of some form of individual results. Fisher (2008) has argued that donors rightfully
expect this latter kind of reciprocity, noting that “we donated parts of ourselves … an almost
sacred act. We entered a covenant, not a contract.” This formation of a relationship of
reciprocity complicates the notion of “altruistic” sample donation, as Haimes and Whong-
Barr (2004) also noted in the case of a UK-based biobank. One LeARN participant clearly
expressed this sense of reciprocity by saying, “We helped them with their study; looks like
they could go a little further and give you the information.”
It is this desire for (and sometimes expectation of) individual results from biological samples
given for research purposes that so often troubles researchers concerned with the informed
consent process (Appelbaum et al., 1987; King et al., 2005). While it is crucial that
researchers continue to work toward the clearest and most transparent consent processes
possible for any study involving human subjects, several studies have also suggested that the
perspectives of donors to genetic and other medical research will necessarily differ from
those of researchers, due to their very different positionality vis-à-vis the research endeavor.
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Few LeARN interviewees told us that they expected to receive diagnostic or treatment
information from the NCCCS study, but many spoke of their samples being analyzed in an
individual way. These results indicate a fundamental difference between what researchers
believed they were communicating about the NCCCS study and the way many research
participants conceptualized the research endeavor. As Dixon-Woods et al. (2007) have
concluded, these latter differences may not be cause for concern unless they lead people to
make decisions about research participation that they would not make if their
misunderstanding were pointed out. The relationship of education level to this difference in
understanding suggests that, as the proportion of Americans who have post–high school
education continues to rise, misunderstandings of the implications of research participation
may decrease.
However, the relationship of race to a belief that research participation may lead to
individual health outcomes may point to a more complicated set of historically based issues.
While race and education were related in our sample, they also varied independently in our
quantitative data. African Americans were nearly as likely as White participants to espouse
altruism or “helping” as a motive for giving samples, but over twice as likely, at the same
time, to look for individual benefits for their participation. Corbie-Smith et al. (2002) found
that African Americans were significantly less trusting of doctors than Whites, even after
controlling for other markers of social class; and, in another study, found that African
Americans in focus groups believed that signing an informed consent document meant that
“you don’t have any legal rights” (Corbie-Smith et al., 1999, p. 540). These results reflect a
long history of racially based discrimination in the U.S. in which African Americans have
been institutionally disadvantaged under the law as well as in medicine, education, housing,
and employment (Smedley, Stith, & Nelson, 2003). The LeARN interviewees, having
already participated in a genetic research study, were more positive about medical research
and researchers than Corbie-Smith et al.’s focus group participants; however, they likely
share similar community memories of past abuses such as the well-known Tuskegee syphilis
study by the U.S. Public Health Service, in which Black participants were deprived of life-
saving information about their condition for many years, and many died (Brandt, 1978;
Corbie-Smith, 1999). Their willingness to participate and overall positive view of research
may not conflict with a belief in the possibility of reciprocation through individual results so
much as they are contingent upon it.
Best Practices
By combining qualitative and quantitative data on a sizable group of sample donors, this
study illuminates some of the complex and overlapping hopes and concerns of genetic
research participants. Genetic researchers can improve their communications with research
participants by taking these hopes and concerns into account and recognizing that the needs,
desires, and understandings of different populations may vary.
The Therapeutic Misconception and the Return of Results
This study found that a large percentage of genetic sample donors, even in a study that took
place outside a clinical environment, did not make a clear distinction between research and
diagnostic testing, leading some to expect individual results despite being informed (at least
in the consent form) that they would not receive such results. Researchers should recognize
when recruiting participants that the common conception of genes as powerful determinants
of health may prevent potential subjects from recognizing subtle language about the lack of
individual benefit from research, particularly when such language is embedded in a multi-
page consent form. Verbal statements in clear language about the intent of the study and its
benefits and risks may deter some misconceptions, but not all. If the return of individual
results is at all feasible, it is preferable, as the opinions of participants in this and many other
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studies have shown. If it is completely unfeasible, researchers should consider a follow-up
communication with participants summarizing the overall results of the study and clearly
stating again that individual results will not be offered. Barring this communication,
researchers should at the very least be prepared to receive and respond clearly to later
questions from participants who may have misunderstood the terms of their participation.
African Americans’ Participation in Research
Both quantitative and qualitative results from the LeARN study show the importance of
historical differences between African Americans and Whites in relation to clinical research.
African Americans’ doubts about the research enterprise will likely remain for years to
come. Researchers who seek to include African Americans in genetic research will likely
continue to need to work harder to gain their trust, and may need to offer incentives (such as
the return of individual results) to make research participation more attractive. Engaging
with minority populations on a community basis (through religious institutions, community
groups, and the like) may yield an ongoing research relationship in which researchers and
participants are more likely to understand and accommodate one another's goals; such
relationships can both encourage research participation and increase mutual satisfaction with
the research partnership (see Corbie-Smith et al., 2010).
Doing Good for Science and One Another
The idea of “helping” was overwhelmingly present in the motivations of genetic research
participants in this study, as in similar ones with other studies and populations. Research
participants repeatedly echo the belief that scientific research contributes to the common
good of society and, therefore, that their participation benefits not only the scientific
enterprise, but one’s own family, neighbors, and community. Because of this, as Hoeyer and
Lynoe (2006) have noted, research participants must place their trust in researchers, research
institutions, and the scientific community as a whole to further their interests in the common
good. The standard of informed consent is a good first step toward ethical relationships with
research participants, but it does not address these larger issues for which participants (and,
to some extent, even individual researchers) cannot possibly take responsibility. To more
fully meet the expectations of research participants, research institutions and the funders
who support them must advance ethical standards on a broader scale, by working to insure
that genetic discoveries are translated into clinically relevant technologies, and that these are
made accessible to all segments of society.
Research Agenda
In this study, we present results from interviews with a large number of participants in a
colon cancer research study regarding their motivations for donating and expectations of
how their sample would be used. It is not a nationally representative sample. Rather, it is a
study of former research participants, likely representatives of future targets of recruitment
efforts as more genetic research builds on existing cohorts (SACGHS, 2007).
Our quantitative results reflect those of other studies on sample donation. Yet our qualitative
analysis give these findings context and depth. In particular, our finding that genetic
research participants in this study viewed their samples primarily as information rather than
as physical substances illuminates the lack of concern on the part of most participants for the
long-term storage of their samples. Further research into the ways that genetic research
participants in other study populations view their samples may lend further support to these
findings, or may alter or refine them in significant ways.
Our quantitative results demonstrate that differences between African Americans and
Whites cannot be reduced to economics or education, and our qualitative findings offer
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intriguing glimpses into some of the complex ways that African Americans relate to medical
research, even when they have agreed to participate in it. Research comparing African
American attitudes among research participants and decliners may illuminate these issues
even further.
Educational Implications
Our finding that many genetic sample donors did not clearly distinguish between giving
samples for research and for clinical testing reflects the findings of many other studies. This
result reinforces the importance of very clear consent processes, but it also reminds us that
even those consent processes may not prevent participants from reaching their own
conclusions, a point that researchers and IRB members must keep in mind when considering
the motivations and incentives for research participation.
Genetic studies that ask for donations of biological samples involve many of the same
ethical and practical issues as any medical research study, among them the need for
recognizing and addressing the complexity of the consent process for research participants,
discovering and overcoming barriers to participation, and finding an ethical balance between
these two. These issues are compounded in the genomic era, as hopes for genetic discoveries
and therapies bring with them additional risks of loss of confidentiality or insurability,
stigmatization, and even challenges to self-perception and community identities. Perceptions
among actual and potential genetic sample donors of researchers as facilitators of their
desires to help improve society as a whole call for conscientious response on the part of
scientists who recruit and utilize tissue donations, for transparency in the former endeavor
and accountability in the latter. Researchers can enhance both of these aspects of their
relationships with research participants by recognizing that very relationship, one that, for
sample donors, does not end with their gift of DNA, but only just begins.
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TABLE 1
Sample Characteristics for Participants Who Contributed Either Blood or Mouthwash (n=772).
Characteristic N(%) or Mean(SD)
Race
    African American 142 (18%)
    White 630 (82%)
Education
    Less than high school 111 (14%)
    High school 190 (25%)
    More than high school 249 (32%)
    College+ 222 (29%)
Age in years (SD) 64.3 (9.93)
Case status
    Case (colorectal cancer) 350 (45%)
    Control 422 (55%)
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TABLE 2
Unadjusted and Adjusted Proportions of “Interested in Own Health” as a Reason for Giving Blood or











    African American 142 88b 87b
    White 615 67 69
Education
    Less than high school 116 86b 83b
    High school 195 76 76
    More than high school 255 73 75
    College+ 224 56 60
Age
    43–55 175 68 70
    56–65 198 71 74
    66–75 271 70 72
    76–82 91 79 79
Case status
    Case (colorectal cancer) 342 76b 77b
    Control 415 66 69
a
Based on results from a logistic regression model, adjusted for race, education, age, and case status
b
p ≤ 0.01
Note: No interaction effect between race and education.
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